Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older than 70 Years; Survival Benefit at Considerable Morbidity and Mortality: A Reply-Reference-Cited by-同舟云学术

Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older than 70 Years; Survival Benefit at Considerable Morbidity and Mortality: A Reply

Published:2017-11-13 Issue:S3 Volume:24 Page:602-602
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Votanopoulos Konstantinos I., ,Shen Perry,Stewart John H.,Levine Edward A.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-017-6220-9/fulltext.html

Reference1 articles.

1. Votanopoulos KI, Newman NA, Russell G, Ihemelandu C, Shen P, Stewart JH, Levine EA. Outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality. Ann Surg Oncol. 2013;20(11):3497–503. https://doi.org/10.1245/s10434-013-3053-z .

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 5‐factor modified frailty index is a novel predictive marker of death from other diseases after curative gastrectomy for gastric cancer;Geriatrics & Gerontology International;2023-08-19

2. Elemene-containing hyperthermic intraperitoneal chemotherapy combined with chemotherapy for elderly patients with peritoneal metastatic advanced gastric cancer;World Journal of Clinical Cases;2022-02-16

3. Hyperthermic intraperitoneal chemotherapy in locally advanced and recurrent ovarian carcinoma: surgical and oncological outcomes in the Indian public healthcare system;Future Oncology;2021-05

4. Outcomes for Elderly Ovarian Cancer Patients Treated with Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC);Annals of Surgical Oncology;2021-01-03

5. Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—a national population-based study;World Journal of Surgical Oncology;2020-04-06